Skip to main content
Erschienen in: Journal of Nuclear Cardiology 3/2019

11.01.2019 | Images that Teach

Myocardial perfusion imaging in non-ischemic cardiomyopathy

verfasst von: Haren Patel, MD, Shane Prejean, MD, Ami E. Iskandrian, MD, MASNC, Fadi G. Hage, MD, MASNC

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Excerpt

A 63-year-old African-American man was referred for exercise SPECT myocardial perfusion imaging (MPI) for the evaluation of non-exertional chest pain of 2-3 months duration that had worsened recently (occurring almost daily). He carries the diagnosis of dilated, non-ischemic cardiomyopathy (NICM) with left ventricular (LV) dysfunction by gated SPECT-MPI and 2-dimensional echocardiography (images not shown). His medication list is shown in Table 1.
Table 1
Baseline medication list
Aspirin 81 mg daily
Furosemide 40 mg daily
Carvedilol 25 mg twice daily
Irbesartan 300 mg daily
Digoxin 0.25 mg daily
Atorvastatin 20 mg daily
Potassium Chloride 10 mEq daily
Spironolactone 50 mg daily
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Danias PG, Papaioannou GI, Ahlberg AW, et al. Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy. Am J Cardiol. 2004;94:14–9.CrossRefPubMed Danias PG, Papaioannou GI, Ahlberg AW, et al. Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy. Am J Cardiol. 2004;94:14–9.CrossRefPubMed
2.
Zurück zum Zitat Caobelli F, Bengel FM. Ischaemic vs non-ischeamic dilated cardiomyopathy: the value of nuclear cardiology techniques. J Nucl Cardiol. 2015;5:971–4.CrossRef Caobelli F, Bengel FM. Ischaemic vs non-ischeamic dilated cardiomyopathy: the value of nuclear cardiology techniques. J Nucl Cardiol. 2015;5:971–4.CrossRef
4.
Zurück zum Zitat Murthy V, Bateman T, Beanlands RS, et al. Clinical quantification of myocardial blood flow using PET: Joint Position Paper on the SNMMI Cardiovascular Council and the ASNC. J Nucl Med. 2018;59:273–93.CrossRefPubMed Murthy V, Bateman T, Beanlands RS, et al. Clinical quantification of myocardial blood flow using PET: Joint Position Paper on the SNMMI Cardiovascular Council and the ASNC. J Nucl Med. 2018;59:273–93.CrossRefPubMed
5.
Zurück zum Zitat McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–9.CrossRefPubMed McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–9.CrossRefPubMed
6.
Zurück zum Zitat Richardson T, Kronenberg M. Reversible myocardial perfusion abnormalities in nonischemic dilated cardiomyopathy. J Nucl Cardiol. 2016;23:1183–5.CrossRefPubMed Richardson T, Kronenberg M. Reversible myocardial perfusion abnormalities in nonischemic dilated cardiomyopathy. J Nucl Cardiol. 2016;23:1183–5.CrossRefPubMed
Metadaten
Titel
Myocardial perfusion imaging in non-ischemic cardiomyopathy
verfasst von
Haren Patel, MD
Shane Prejean, MD
Ami E. Iskandrian, MD, MASNC
Fadi G. Hage, MD, MASNC
Publikationsdatum
11.01.2019
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 3/2019
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-018-01577-9

Weitere Artikel der Ausgabe 3/2019

Journal of Nuclear Cardiology 3/2019 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.